Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biopharma IncfiledCriticalJanssen Biopharma Inc
Priority claimed from PCT/US2015/037001external-prioritypatent/WO2015200219A1/en
Publication of MA40032B1publicationCriticalpatent/MA40032B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Saccharide Compounds
(AREA)
Abstract
L'invention concerne des nucléosides, des nucléotides et des analogues de nucléotides, des procédés de synthèse de ceux-ci et des procédés de traitement de maladies et/ou d'états pathologiques, tels qu'une infection virale par les coronaviridae, les togaviridae, les hepeviridae et/ou les bunyaviridae, avec un ou plusieurs nucléosides, nucléotides et analogues de nucléotides.The invention relates to nucleosides, nucleotides and nucleotide analogs, methods of synthesis thereof and methods of treating diseases and / or disease states, such as viral infection by coronaviridae, togaviridae. , hepeviridae and / or bunyaviridae, with one or more nucleosides, nucleotides and nucleotide analogues.
MA40032A2014-06-242015-06-22
Substituted nucleosides, nucleotides and analogs thereof for treating viral infections
MA40032B1
(en)